Drägerwerk Stock - long-term strategy and business model under the microscope

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 11:21 CET. Details in the imprint.

Drägerwerk (DE0005550636) is a mid-cap German medical and safety technology specialist whose stock represents a long-established family-controlled business from Lübeck. With no fresh ad-hoc or major analyst headlines, the focus this Saturday is on its long-term strategy and business model.

How Drägerwerk is positioned

Drägerwerk AG & Co. KGaA describes itself as a globally active company in medical and safety technology with a focus on hospital, industrial and mining customers. Its headquarters are in Lübeck, Germany, and the company has existed since 1889.

The group’s activities are structured into two main segments: medical technology and safety technology. Medical technology concentrates on intensive care, emergency care, operating rooms and neonatal care, while safety technology serves industrial, fire service and mining applications.

Long-term strategy and business model

According to the company, Drägerwerk targets sustainable growth in both segments by focusing on high-quality, technically sophisticated equipment and system solutions rather than purely low-cost products. This includes devices, software and associated services such as maintenance and training.

The business model aims at long product lifecycles and recurring revenue from consumables, service and upgrades, particularly in ventilation, anesthesia and gas detection solutions. This structure can cushion cyclical swings in hardware demand and support more stable cash flows over time.

Capital-market profile and index role

Drägerwerk’s preferred shares with ISIN DE0005550636 are listed in Frankfurt and form part of the SDAX, the small-cap index of Deutsche Börse. This places the stock among German small and mid caps with a focus on domestic investors.

Market data providers classify Drägerwerk primarily within the medical equipment and devices universe, even though the safety technology segment gives it a second pillar beyond hospitals. This dual exposure differentiates the company from pure-play medical-technology peers.

What the company sells

One representative Drägerwerk product is the Dräger Evita ventilator line for intensive care units, which is used for mechanical ventilation of critically ill patients in hospitals worldwide. This flagship line illustrates the company’s focus on life-critical technology and close cooperation with clinical users.

Where the stock trades today

Drägerwerk preferred shares (DE0005550636) trade in Frankfurt, with the most recent quoted price on Xetra around the mid-double-digit euro range as of 06/20/2026, 11:21 CET, reflecting its status as an established German small-cap in medical and safety technology.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.